Green Thumb Industries Logo
CA39342L1085
A2JN3P
GTBIF

Green Thumb Industries

Caricamento quotazioni...

Previsioni

Il prezzo obiettivo medio degli analisti è 15,46 € (+136,39%). La mediana è 15,46 € (+136,39%).

Acquista
  5
Mantieni
  0
Vendi
  0

  • Green Thumb Industries positioned for selective post-rescheduling M&A rather than megadeals

    After Curaleaf's takeover bid for Aurora Cannabis, Green Thumb Industries is well capitalized and likely to pursue disciplined, smaller acquisitions or distressed state-level assets rather than large megamergers. Rescheduling cannabis to Schedule III would reduce tax burdens and increase sector deal activity, but Green Thumb's management favors cash-flow preservation, buybacks and strict return thresholds. The company can use its cash and stronger balance sheet to pick up valuable real estate, licenses or processing capacity in high-conviction markets. » Altro su finance.yahoo.com


  • Green Thumb exceeds revenue forecast for Q2 2026, margins under pressure

    Green Thumb reported Q2 revenue of $307 million, beating the consensus estimate; normalized EBITDA was $84 million. Gross margin fell from 50% to 45% and same-store sales declined by about 1%. Management expects stagnant revenue in Q3 due to price pressure, but emphasizes cash-flow strength, share buybacks and long-term growth drivers. The stock rose modestly in after-hours trading, up 2.44% to $10.09. » Altro su de.investing.com


  • Green Thumb Industries posts profitable Q1, strong cash flow and $78M in buybacks

    Green Thumb Industries reported Q1 revenue of $300.2 million, up 7.4% year‑over‑year, generating $76 million in operating cash flow, $93.5 million in normalized EBITDA and GAAP net income of $15.4 million. The company finished the quarter with about $344.5 million in cash against $289.9 million of debt and has repurchased roughly 13.4 million shares year‑to‑date for nearly $78 million. Management is pursuing selective retail growth while emphasizing profitability amid ongoing industry headwinds like federal uncertainty, high tax burdens under Section 280E and pricing pressure in mature markets. » Altro su finance.yahoo.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Green Thumb Industries ha registrato ricavi pari a 268,72 Mln € e un utile netto di 4,27 Mln €
(EUR) giu 2026
YoY
Ricavi 268,72 Mln 8,00%
Utile lordo 120,81 Mln 2,64%
Utile netto 4,27 Mln 881,05%
EBITDA 57,09 Mln 3,63%

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
1,43 Mld €
Numero di azioni
218,99 Mln
Massimo/minimo a 52 settimane
8,96 € - 4,54 €
Dividendi No
Beta
0,92
Rapporto P/E
13,88
Rapporto PEG
0,04
Rapporto P/B
0,90
Rapporto P/S
1,43

Profilo aziendale

Green Thumb Industries Inc. beschäftigt sich mit der Herstellung, dem Vertrieb und dem Verkauf verschiedener Cannabisprodukte für den medizinischen Gebrauch und den Gebrauch durch Erwachsene in den Vereinigten Staaten. Es bietet Cannabisblüten sowie verarbeitete und verpackte Produkte an, darunter Pre-Rolls, Konzentrate, Vapes, Tinkturen, Esswaren, topische Produkte und andere cannabisbezogene Produkte unter den Marken Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles und RHYTHM. Das Unternehmen vertreibt seine Produkte in erster Linie an Einzelhandelsgeschäfte von Dritten und verkauft fertige Produkte direkt an Verbraucher in seinen eigenen Einzelhandelsgeschäften. Am 11. April 2022 besaß und betrieb es 77 Einzelhandelsgeschäfte in den Vereinigten Staaten. Das Unternehmen wurde im Jahr 2014 gegründet und hat seinen Hauptsitz in Chicago, Illinois.

Nome
Green Thumb Industries
CEO
Benjamin Kovler
Sede centrale Chicago, il
Canada
Sito web
Settore
Sanità
Industria
Prodotti farmaceutici
Quotazione in borsa
14/06/2018
Dipendenti 5000

Simboli di borsa

Borsa Simbolo
Pnk
GTBIF
Cnq
GTII.CN
Frankfurt
R9U2.F
Düsseldorf
R9U2.DU
München
R9U2.MU
🍪

Parqet  usa i cookie. Scopri di più